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Abstract: 
Background: 
 West Nile virus (WNV) is an arboviral disease that has caused an estimated 29,624 
clinical illnesses and 1,161 deaths in the United States since its emergence in 1999.  A national 
WNV surveillance program was established by the Center for Disease Control and Prevention by 
providing states with grant funds to construct surveillance systems in 2000.  Kansas launched 
statewide surveillance efforts in 2001.  This project describes the evaluation of the WNV 
surveillance system in Kansas to determine its level of effectiveness as a public health tool 
including recommendations to improve the system. 
 
Methods 
 The surveillance system was evaluated utilizing the CDC’s 2001 MMWR Updated 
Guidelines for Evaluating Public Health Surveillance Systems.   The surveillance system was 
also compared to the CDC’s Epidemic/Epizootic West Nile Virus in the United States: Guidelines 
for Surveillance, Prevention, and Control published in 2003.  Key personnel in Kansas and 
neighboring states were interviewed during this evaluation.  Mosquito pool collection data was 
evaluated for 2008 and 2009 for time lapse between collection and reporting of results.  Records 
from Kansas’s Electronic Disease Surveillance System 2003-2009, were analyzed using SAS 
9.1.3 to determine number of days between non-human cases and human illness onset dates.  A 
WNV surveillance system survey was created and utilized to interview public health officials in 
4 surrounding states. 
Results 
 Mosquito pool collection is conducted in 13 of 105 Kansas counties by the Kansas State 
University Entomology Department between May and October of each year.  For 2008 and 2009, 
the combined range of time between collection and reporting of mosquito pool results was 6-87 
days with a median of 23 days.  When positive mosquito data was compared to human onset 
dates for 2003-2009 the time between positive mosquito pools and positive human cases, ranged 
from 36 days prior to human illness onset to 82 days after with a median of 24 days after human 
onset dates.  
 
Conclusions    
 WNV is now considered endemic in the state of Kansas and is an established seasonal 
health threat for its residents. Mosquito pool collection data was shown to be a poor predictor of 
human disease.  The timeliness of testing, reporting of results, and the evidence of human cases 
prior to detection in mosquito populations indicates that this method of surveillance is not 
providing adequate information to implement public health interventions.    Resources would be 
better utilized if they were focused on educational efforts in disease prevention and mosquito 
control measures.  
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Introduction: 
 
West Nile virus (WNV) was first isolated in 1937 from a febrile woman in the West Nile 
district in the Northern Province of Uganda (1).  In the years that followed its discovery, it was 
determined to be transmitted by mosquitoes and to have an avian amplification component to the 
lifecycle (2).   After the original isolation of WNV, the virus has been implicated in sporadic outbreaks 
of mild illness in Africa, the Middle East, western Asia, and Australia (3).  The first human cases 
resulting in death associated with WNV encephalitis were reported in Israel in the 1950s (4).  Since the 
mid-1990s, the frequency and severity of WNV outbreaks have increased with outbreaks in Romania 
(1996), Russia, the United States (1999) and Israel (2000) (5) (6).   Equine encephalitis associated with 
WNV was first identified in the 1960s, with the largest equine outbreak occurring in France in 2000 
(7) (8).   The virus was limited to the Old World until it made its début into the Western Hemisphere in 
New York City in 1999 (9).  Since that time, the virus has spread across the United States, Canada and 
has been documented in Mexico and the Caribbean (3). 
West Nile virus is a single-stranded RNA virus in the family Flaviviridae, genus Flavivirus.  
Serologically, it is a member of the Japanese encephalitis virus antigenic complex, which includes St. 
Louis, Japanese, Kunjin (Australian subtype of WNV), and Murray Valley encephalitis viruses (10).  
The virus is maintained in an enzootic bird-mosquito-bird cycle until significant amplification allows 
for bridge-vector mosquitoes (mosquitoes that feed on both humans and birds) to transmit the virus to 
humans and other animal species (11).   Viral amplification occurs in the enzootic cycle until late 
summer to early fall when female bridge-vector mosquitoes begin diapause and start taking blood 
meals.   Humans and other mammalian species are considered to be incidental host because they do 
not develop sufficient viremias to contribute to mosquito transmission (7).    
Although 64 species of mosquitoes have been reported to the Center for Disease Control and 
Prevention (CDC) to be carriers of the West Nile virus, not all have the ability to transmit the virus.  
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Of the mosquito species identified with the virus, those of the Culex species have been thought to be 
the most important in transmission.  Culex pipiens, Cx. restuans, and Cx. quinquefasciatus are 
considered to be the most important maintenance vectors because they are primarily ornithophilic, 
abundant, and have been shown to have high incidence of WNV (12) (13).  Mosquito species suspected 
of contributing the most to transmission to humans include Culex pippins L. and Cx. restuans in the 
northeastern and north-central regions, Cx. tarsalis and Cx. quinquefasciatus in the western United 
States and Cx. nigripalpus and Cx. quinquefasciatus in the southeastern regions (13) (14).  
Most WNV infections in humans occur from the bite of an infected mosquito; however, other 
modes of transmission have been documented.  Novel modes of transmission include blood 
transfusion, organ transplantation, breast milk ingestion, intrauterine, and occupational exposure (3).  
West Nile virus infections in humans can cause a spectrum of manifestations ranging from no clinical 
symptoms to severe neurologic signs and death (5).  Clinical disease may appear after an incubation 
period of 3-14 days and symptoms last from 3-6 days(15).  The majority of human infections are 
asymptomatic.  A serosurvey conducted during the 1999 New York outbreak, showed approximately 
20% of infected persons developed clinical signs, and of these, only half visited their physicians (11).    
West Nile virus Fever (WNF) is described as a febrile illness of sudden onset with non-
specific flu-like symptoms.  Patients may have high fever, malaise, anorexia, nausea, vomiting, 
headache, mayalgia, lymphadenopathy, and retro-orbital pain (5) (10).  A maculopapula or pale roseolar 
rash was reported in some patients and was more commonly noted in children (10).  In addition to 
WNF, an infection may result in West Nile Neuroinvasive Disease (WNND).  Those affected with 
WNND usually have a febrile prodrome before the development of neurological symptoms (10).  It is 
estimated that only 1 in 150 patients with WNF progress to severe neurologic illness (11).  The 
neurological signs associated with WNV are similar to other flaviviruses and depend on the section of 
the nervous system affected.  Clinical signs may be associated with inflammation of the meninges 
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(meningitis), the brain parenchyma (encephalitis), the spinal cord (myelitis) or any combination of 
the above.   In rare cases, patients may present with an acute polio-like flaccid paralysis (5).   
 There is no established treatment for West Nile virus infection or a preventative vaccine for 
humans.  Severe cases require hospitalization with supportive care of complications such as 
respiratory paralysis, pneumonia, pressure sores, and seizures (10).  Case fatality rates among patients 
hospitalized during recent outbreaks have ranged from 4-14%.  These rates were higher among older 
patients (11).  Advanced age is the most significant risk factor for death, with patients over 70 years 
old being most at risk (5).  Survivors of neuroinvasive WNV disease can have significant long-term 
deficits including fatigue, memory loss, difficulty walking, muscle weakness, and depression 18 
months or more following infection (5) (16) . 
WNV in the Western Hemisphere 
 
West Nile virus made its début into the Western Hemisphere in New York City and 
surrounding areas in 1999 (9), when in late August and early September these areas experienced an 
outbreak of human encephalitis.  These cases were consistent with an arboviral disease and were 
initially indicated to be caused by the North American St. Louis Encephalitis virus (SLEV) (17).  
SLEV and WNV are closely related and cross-react on serological tests.  Simultaneously, it was 
noted that American crows (Corvus brachyrhynchos) and fish crows (Corvus ossifragus) were dying 
of viral encephalitis in the same geographic area as the human encephalitis cases (18).  In addition to 
crows, deaths of several exotic avian species occurred in zoological parks in the Bronx and Queens 
during the same time period (4).  Necropsy samples taken from Chilean flamingos (Phoenicopterus 
chilensis) from the Bronx zoo were submitted to the National Veterinary Services Laboratory 
(NVSL) where a flavivirus-like particle was identified by electron microscopy.  The isolates were 
forwarded to the CDC for identification (18) (4).  The viral isolates were determined to be from a strain 
of the West Nile virus.  
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After the identification of WNV in avian species, human serologic results were re-evaluated 
to include WNV in the screening panel.  Patients previously thought to have SLEV had stronger 
serologic reactions to WNV than to the SLEV (17).  It was determined at this time that the two 
outbreaks were associated.  Shortly after the observation of avian and human cases of encephalitis, 
veterinarians in the New York City area started to see cases of equine encephalitis as well.   Necropsy 
samples from four horses were sent to either the NSVL or to the CDC and were identified to be 
infected with WNV.  In the 1999 outbreak, twenty equines with neurologic disease were confirmed as 
WNV cases by either positive plaque reduction neutralization test (PRNT) titer to WN virus or 
isolation of virus confirmed by primer sequence (19).   
The West Nile virus strain isolated from the 1999 New York outbreak (NY99) was almost 
identical to a strain that had circulated  in Israel from 1997 to 2000 (6) (18).  This genetic similarity 
suggests that the virus was imported to the Western Hemisphere from the Middle East.  Although the 
exact method of introduction will remain unknown, several theories have been introduced, including 
introduction of an infected human or bird, or the unintentional importation of a WNV-positive 
mosquito (3) (5).    
Public health officials feared that WNV would overwinter and begin another epidemic in the 
spring of 2000, this proved true when the virus was found to overwinter in populations of female 
Culex mosquitoes.  The CDC and the U.S. Department of Agriculture (USDA) recommended that 
surveillance efforts be initiated along the Atlantic and Gulf coasts from Massachusetts to Texas (20).  
Unlike in the Old World, WNV caused a significant mortality rate in avian species, especially in the 
Corvid family (crows, jays and magpies).  These avian deaths provided one simple way for the nation 
to track the spread of the virus.  In 2000, the virus spread north and south from New York City, and it 
reached the southeastern United States, including the Florida Keys, the summer of 2001.  In 2002 the 
first cases were documented in Canada, Mexico, Jamaica, Guadeloupe and the Dominican Republic 
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(4).  By 2005, West Nile virus had successfully spread across the United States, being documented in 
all lower 48 states and the District of Columbia.   
Since the introduction of WNV into the United States, there have been a total of 29,624 
human cases reported to the CDC.  Of the 29,624 cases, 12,088 (40.8%) were reported WNND, 
16,765 (56.6%) were reported as WNF, 771 (2.6%) were clinically unspecified at this time.  Of the 
total number of cases, 1,161 (3.9%) of cases were reported to be fatal.   
WNV in Kansas 
 
In 2001, the Kansas Department of Health and Environment (KDHE) started a West Nile 
virus surveillance program using funds provided by Epidemiology Laboratory Capacity (ELC) grant 
from the CDC.  The original surveillance was started to track the spread of WNV in the United States 
and to provide information about potential vectors, seasonality, geographic areas of increased activity 
and potentially susceptible species.  At this time, surveillance efforts included voluntary submission 
by the public of dead birds for testing, mosquito pool collection, and reporting human, equine and 
other animal cases.  Positive avian and other animal results are not required to be reported and 
reporting was done as an agreement between testing laboratories and the KDHE. 
The first WNV activity in Kansas was identified in a mosquito pool of Culex tarsalis 
mosquitoes collected on July 23, 2002. The first documented case of WNV in Kansas appeared on 
August 8, 2002 when a horse was reported to be infected.   The first human case had an onset date of 
August 6, 2002.  In 2002, 103 of 105 counties reported WNV in horses, birds, mosquitoes, or 
humans.  There were 22 reported human cases in 2002 with the epidemic continuing in 2003 when 90 
people were reported with WNV fever, meningitis, encephalitis, or acute flaccid paralysis.  Since this 
outbreak, Kansas has reported West Nile virus activity in the state every year.   
In 2009, WNV surveillance included passive human disease reporting and mosquito pool 
collection and testing.  Since 2002, in accordance with K.S.A. 65-118 and K.S.A. 65-128, all 
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arboviral diseases, including West Nile virus, Western Equine Encephalitis, and St. Louis 
encephalitis must be reported to KDHE, Division of Health, Bureau of Surveillance and 
Epidemiology within 7 days of confirmed or suspect cases.  Cases are reported by health care 
providers, hospitals and laboratories across the state.   
Mosquito pool testing begins in May and continues until late fall.  In 2009 mosquito testing 
was conducted in 13 counties in an attempt to represent all five regions of the state.  CDC miniature 
light traps model 512, were used for mosquito collection.  Traps were set after 3pm in locations near 
standing bodies of water.  Traps were left overnight and retrieved the following morning.  The 
collection cups were removed from the traps and tied shut.  The cups were then placed in a cooler 
with dry ice to facilitate freezing of the mosquitoes.  Once the mosquitoes were frozen, they were 
placed in a Nalgene bottle labeled with city, date, and trap site.  The collection cups were stored in a -
80o C freezer until processed.  The mosquitoes are sorted by species; all non-Culex mosquitoes were 
discarded.  The Culex species mosquitoes were sorted into pools of 1-50 mosquitoes from each site.  
For testing there were at least 5 mosquitoes for Culex pipiens and 7 mosquitoes for all other Culex 
species.  Once they had been sorted and pooled they were submitted to the Kansas Health and 
Environmental Laboratory for testing for WNV.  Mosquito pools were tested by reverse transcriptase 
(RT)-PCR with similar protocol as described by Lanciotti et.al (24).   
Results were submitted to the Bureau of Surveillance and Epidemiology and a quality 
assurance coordinator enters the data into a Microsoft Excel® spread sheet.   Both human and 
mosquito pool results are entered into Kansas’s Electronic Disease Surveillance System (KS-EDSS), 
an electronic database system.  This system is used to share information with the CDC through 
ArboNet, a national, electronic surveillance system established and maintained by the CDC to assist 
states in tracking mosquito-borne diseases.  The State Epidemiologist, Mr. Charlie Hunt, MPH, and 
local health departments are notified via e-mail of any positive results. 
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 The emergence of West Nile virus in the Western Hemisphere was a major event in 
arbovirology.  Not only because of potential disease outbreaks, but also because it reminded the 
world that pathogens are dynamic and with increased global movement of people and goods, the 
threat of disease invasion is constant.  The introduction of a pathogen into an area where there are 
competent vectors and a naïve human population can prove to be devastating.  At the time of the 
1999 outbreak, the United States had limited capacity for arboviral surveillance and control 
measures; the entry of WNV unveiled a substantial weakness in the U. S. public health system.  
Although the United States has several other mosquito-borne encephalitis diseases such as Eastern 
and Western Equine Encephalitis and St. Louis Encephalitis, most states had no standing arboviral 
surveillance or control measures in place.   
Until the WNV epidemic, the United States had not dealt with a large scale outbreak of viral 
encephalitis since 1974 when St. Louis Encephalitis virus caused 1,967 cases across 32 states.  When 
WNV emerged and started to spread across the continent, states were encouraged and provided 
funding to develop and implement programs for surveillance, prevention and control (17).  These 
surveillance efforts were focused on identifying and documenting WNV infections in birds, 
mosquitoes and equines as sentinel animals that would alert health officials to the possibility of 
human disease. 
It is important to periodically evaluate public health surveillance systems to ensure that 
problems of public health importance are being monitored efficiently and effectively. Evaluating 
surveillance systems help to improve the quality, efficiency, and usefulness of the program.  
Currently Kansas conducts WNV surveillance by monitoring human cases and by testing mosquito 
pools collected in specific areas of the state for the virus.   
The main focus of this current evaluation is the comparison of mosquito testing and human 
infections.  The time lapse between collection of mosquito pools and reporting of results, correlation 
 8 
 
of positive mosquito pools and human cases and use of data collected from the surveillance system 
were are analyzed in this evaluation.  In addition, historical data was analyzed to determine the 
timing between animal and avian cases compared to human cases by county to determine if previous 
methods of surveillance provided quality sentinel information.  The results of this current evaluation 
will be utilized by the KDHE to make further decisions about the course of action for the West Nile 
virus surveillance system in Kansas.  
Materials and Methods: 
 
With the help of the KDHE Bureau of Surveillance and Epidemiology staff and my direct 
supervisor Dr. Ingrid Garrison, DVM, MPH, DACVPM, the Environmental Health Officer and State 
Public Health Veterinarian, the West Nile virus surveillance system was evaluated using the 
guidelines described in the CDC’s 2001 Updated Guidelines for Evaluating Public Health 
Surveillance Systems.  The surveillance system was also compared to the CDC’s Epidemic/Epizootic 
West Nile Virus in the United States: Guidelines for Surveillance, Prevention, and Control published 
in 2003.  
Engage the Stakeholders  
 
The first step in evaluating the surveillance system is to engage the stakeholders.  
Stakeholders are defined as “persons or organizations that use data for the promotion of healthy 
lifestyles and the prevention and control of disease, injury, or adverse exposure” (21).   People directly 
involved with the surveillance system were interviewed by direct communication.  Dr. Ludek Zurek, 
Associate Professor in the Entomology Department at Kansas State University, supervisor and 
coordinator for mosquito pool collection, was interviewed on November 10, 2009 to discuss the 
mosquito pool collection and testing process.  Dr. Roman Ganta, Associate Professor in the 
Department of Diagnostic Medicine/Pathobiology at Kansas State University was interviewed on 
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January 9, 2010.  Dr. Ganta supervises the virology lab at the Kansas State University Veterinary 
Diagnostic Laboratory.  This is where avian, equine and other animal testing for WNV is conducted.  
In the interview we discussed the number of equines tested annually and the method of reporting for 
horses.  Administrators from local health departments in counties that had a positive mosquito pool in 
2009 were contacted on January 20, 2010 to determine how they respond to the notification of a 
positive pool.   
Describe the Public Health Importance 
 
 Data for the state of Kansas was retrieved through the Kansas Electronic Disease Surveillance 
System (KS-EDSS).  Cases were evaluated from January 1, 2002 to December 31, 2009.  West Nile 
virus cases are classified as either suspect, probable, or confirmed for surveillance purposes. This 
classification is based on a combination of clinical disease and supporting laboratory data.  
Laboratory criteria for diagnosis is defined by the CDC as: a four-fold or greater virus specific serum 
antibody titer, or; isolation of virus from or demonstration of specific viral antigen or genomic 
sequences in tissue, blood, cerebrospinal fluid (CSF), or other body fluid, or; virus-specific 
immunoglobulin M (IgM) antibodies demonstrated in CSF by IgM antibody-capture enzyme 
immunoassay (EIA), or; virus-specific IgM antibodies demonstrated in serum by EIA and confirmed 
by demonstration of virus-specific serum immunoglobulin G (IgG) antibodies in the same or a later 
specimen by another serologic assay (e.g., neutralization or hemagglutination) (22).   
Confirmed cases are cases with clinical symptoms consistent with West Nile virus associated 
illness and with one of the laboratory diagnostics listed above.  Probable cases are defined as an 
encephalitis or meningitis case, with or without neurological involvement, occurring during a period 
when arboviral transmission is likely and with the following supportive serology: a single or stable 
(less than or equal to two-fold change) but elevated titer of virus-specific serum antibodies, or; serum 
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IgM antibodies detected by antibody-capture EIA but with no available results of a confirmatory test 
for virus-specific serum IgG antibodies in the same or a later specimen.  Cases that do not meet the 
criteria for confirmed or probable status remain suspect cases.   
Only cases classified as confirmed or probable were identified in the data search and, exported to a 
Microsoft Excel® spread sheet.  Names and address of individuals were not included in exported data 
to maintain privacy of the patients.    Data was separated into case classifications of 
encephalitis/meningitis, fever, other clinical/unspecified, fatalities and total numbers.  These numbers 
were separated by year.  Cases were evaluated by clinical classification, age, and sex.  All cases from 
years 2002-2009 were plotted on an epi-curve by the established Morbidity and Mortality Weekly 
Report (MMWR) week.  The Morbidity and Mortality Weekly Report is a weekly scientific 
publication prepared and published by the CDC which contains data and reports on specific health 
and safety topics.   
Timeliness  
 
Time between mosquito collection and reporting of test results to KDHE was evaluated.  
Years 2008 and 2009 had adequate data for this evaluation.  To determine the usefulness of mosquito 
pool testing, avian and other animal cases as sentinels for human illness, data was analyzed to 
determine the number of days between positive non-human cases and positive human cases.  Non-
human cases include mosquito pools, avian and animal cases.  Animal cases included all animal 
species except for avian and mosquito cases. We compared report date of non-human cases to onset 
of illness for human cases by county.  Data was used from 2003 to 2009; cases from 2002 were 
excluded due to lack of mosquito pool test results.    All mosquito pools, avian and animal cases were 
exported from KS-EDSS.  All positive human, mosquito pools, avian, and animal pools were 
analyzed using SAS 9.1.3 to calculate the days between non-human cases and human cases that 
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occurred in the same year and the same county.  The range and median was calculated when there 
was enough data for this analysis.   
 Onset dates for human illness and mosquito pool result dates were separated by MMWR week 
and by year for years 2003-2006 and 2008-2009.  Mosquito collection was not performed in 2007.   
Human and mosquito data was exported from KS-EDSS and entered into Microsoft Excel (2007) 
spreadsheets.  These spreadsheets were then utilized to demonstrate graphically when human and 
mosquito pools peek by MMWR week.  
Other States 
 During this evaluation, the state’s neighboring Kansas (Oklahoma, Missouri, Nebraska, and 
Colorado) were all interviewed by phone or with an e-mailed questionnaire on March 3, 2010.  The 
purpose of these interviews was to compare Kansas’s system to neighboring states and to gain ideas 
of other efforts in the prevention and control of WNV.  The main points of the interview were to 
determine what types of surveillance is being done and if monitoring will continue.  Contact 
information for individuals is available in Appendix C.       
Results: 
Describe the Public Health Importance 
 Of the 890 human cases entered into KS-EDSS, 877 were Kansas residents, of these 153 cases 
were confirmed and 142 were of probable status.  Of the 295 human cases, 194(65.8%) cases were 
reported as West Nile neuroinvasive disease, 99(33.6%) as West Nile fever, 2 (0.68%) were clinically 
unspecified, and 13 (4.4%) of cases were reported to be fatal.  Human case break down by year is 
demonstrated in Table 1.  
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Table 1. Human Cases in Kansas Reported in EDSS January 1, 2002 - December 31, 2009 
Year Encephalitis/Meningitis Fever Other Clinical/ 
Unspecified 
Totals Fatalities 
2009 3 10 0 13 0 
2008 14 17 0 31 0 
2007 14 26 0 40 2 
2006 17 13 0 30 4 
2005 17 8 0 25 1 
2004 18 25 0 43 2 
2003 89 0 2 91 4 
2002 22 0 0 22 0 
Totals 194 99 2 295 13 
 
 Number of human cases and fatalities by year are represented in Figure 1.  The highest 
incidence occurred in 2003 with 91 reported cases and 4 fatalities.  In 2006 there were 4 fatalities as 
well but only 30 cases were reported.  The incidence decreased considerably from 2008 with 31 cases 
to 2009 with only 13 reported cases.  The incidence rate in 2003 was 3.4 cases per 100,000 
individuals in Kansas, this compared to 1.4 cases per 100,000 on the national level.  In 2008, the 
incidence rate for Kansas was 0.2 cases per 100,000 compared to 0.4 nationally.  The age of cases by 
range and median are noted by year and the number and percent of total for sex of cases is reported in 
Table 2.  For all years the age of cases ranged from 1 to 94 years of age with a median of 52.  Of all 
cases, 59.2% were male, 39.8% were female and 3 cases (1%) had no sex recorded.    
Table 2.  All Human Cases by Age and Sex for Years 2002 - 2009 
Year Age (years) Sex 
Range Median Male Female Unknown 
2009 2-81 51 8 (61.5%)  5 (38.5%)  
2008 5-83 43 16 (53%) 14 (47%)  
2007 1-86 52 20 (49%) 21 (51%)  
2006 9-86 57 20 (65%)  11 (35%)  
2005 16-86 57 19 (76%) 6 (24%)  
2004 7-84 48 29 (62%) 18 (38%)  
2003 2-94 54 64 (60%) 39 (37%) 3 (3%) 
2002 8-83 51 15(58%) 11 (42%)  
 
From 2002-2009 the highest number of cases were seen in the >55 years of age group seen in 
Figure 2.  In addition, that group had the highest proportion of WNND with 103 of 135 cases (76.3%) 
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compared to the next highest group, 36-54 years of age, with 53 of 86 cases (61.6%) noted in Figure 
3.  When cases are evaluated by date of onset of illness, shown in Figure 4, the peak WNV season 
appears to be from week 29 to 41.  One case with a MMWR week of 5 was excluded from the data 
set.  The MMWR weeks 29-41 correspond to approximately mid-July to mid-October.   
Figure 1.  
 
  
 
Figure 2.  
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Figure 3.
 
 
Figure 4. (Note: One case with MMWR week of 5 was excluded from this data) 
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probable status.  There were 122 animal cases reported; of the 365 avian cases in KS-EDSS, 205 
were positive cases; of the 2992 mosquito pools entered into the system, 115 were positive. 
The time between non-human and human cases are summarized by year in Appendix A. 
Fields with N/A indicated that there were no non-human and human cases that occurred in the same 
county.  When all years were combined, animal cases ranged from 49 days prior to human cases to 
110 days after human cases, with a median of 22.5 days after to human cases.  Avian cases ranged 
from 60 days prior to human cases, to 58 days after human cases with a median of 1 day after human 
cases.  Positive mosquito pools ranged from 36 days prior to human cases to 82 days after human 
cases, the median for positive pools was 24 days after human cases.  These numbers are demonstrated 
in Table 4.   
Table 3. Time Between Mosquito Pool Collection and Report Date 
Year Range (days) Median (days) 
2009 6-87 22 
2008 6-43 24 
 
Table 4. Time Between Non-Human and Human Cases in the Same County for 2003-2009 
All Years Animal to Human (days) 
N= 24 
Avian to Human (days) 
N=49 
Mosquito to Human (days) 
N= 16 
Range 49 prior to 110 after 60 prior to 58 after 36 prior to 82 after 
Median 22.5 after 1 after 24 after 
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Mosquito pool result dates and human illness onset dates by MMWR week for combined 
years of 2003-2006 and 2008-2009 can be found in Figure 5.  MMWR week separation for all years 
can be found in Appendix B.  For all years combined, human cases began to rise on MMWR week 25 
and peaked week 32 while mosquito pools started to rise in week 32 and peeked on MMWR week 39.    
Figure 5. 
 
* Excludes data from 2007 – Mosquito pool collection was not performed in 2007  
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 All four states indicated that the State Health Department issues press releases for the first 
positive test result for each county.  All states indicated that the level of surveillance would not be 
continued if funding from the CDC is terminated.  Only one state indicated that continued 
surveillance would be possible without funding; all others were unsure at this time but were not 
optimistic about continued surveillance.   One state had expressed concern that if mosquito 
surveillance was no longer conducted, their city mosquito control agencies might have difficultly 
obtaining permits for larvicidal application with the stronger regiments set by the National Pollutant 
Discharge Elimination System (NPDES), which controls water pollution by regulating point sources 
that discharge pollutants into waters of the United States.  Another state had expressed the need for 
an increased amount of mosquito based surveillance for other potential emerging arboviral diseases 
such as Dengue and Malaria.  
Discussion:      
In 2009 mosquito pool collection was conducted in 13 of 105 counties (12%) in Kansas.  
These counties were: Scott, Finney, Trego, Graham, Mitchell, Barton, Pratt, Riley, Butler, Shawnee, 
Coffey, and Crawford.  In 2009 there were 4 positive mosquito pools in three counties; Scott, Finney 
and Trego.  When administrators for these 3 counties were contacted, all indicated that they did not 
increase mosquito control for the indicated area or release an announcement to the public.  All 
counties did express that if a public service announcement (PSAs) was given to them that they would 
release it to local media sources.  The major goal of mosquito-based surveillance is to provide 
sentinel information for public health officials to increase mosquito control and education efforts in 
an attempt to decrease human exposure and disease.  After we evaluated mosquito-based surveillance 
in the state of Kansas it was determined that mosquito pool testing was not a predictor of human 
disease. 
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 Positive animal cases, including equine cases, were voluntarily reported to KDHE from 2002 
– 2007.  With the introduction of an effective vaccine for horses, the number of cases declined 
dramatically.  The number of horses tested at the Kansas State Veterinary Diagnostic Laboratory has 
decreased over the last few years to less than 10 tested in 2009 and no positive results recorded.  
Equine cases had been thought to be good sentinel animals because they are highly conspicuous, 
numerous, and widely distributed in some areas. They may be particularly useful sentinels in rural 
areas, where dead birds may be less likely to be detected.  According to the CDC in 2002, “equine 
WNV disease cases were the first indication of WNV activity in 95 (16%) of the 589 counties where 
human disease was reported. The majority of these 95 counties were located in the central and 
western U.S.” (23)   When Kansas equine date was analyzed, it was determined that equine cases were 
not effective sentinels for human illness in Kansas.  The median time between animal and human 
infections was 22.5 days after human illness onset dates.         
When we evaluated avian cases as sentinel species in Kansas it appeared that although avian 
cases appeared before human cases it was still not of adequate lead time for effective control 
measures to be implemented to prevent human infections.  According to the CDC, avian 
morbidity/mortality surveillance had appeared to provide the most sensitive system for early 
detection for WNV activity.  The guidelines set forth by the CDC encourage avian surveillance to be 
a component of every state’s arbovirus surveillance system.  Kansas conducted avian surveillance 
from 2001 to 2006 by testing dead birds submitted by state residents.  This method of surveillance 
was discontinued in 2007 when only 2 birds were submitted for testing in 2006.  It was concluded at 
that time that minimal data was being collected and deemed non-useful as an indicator for human 
cases.   
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Conclusions:  
Mosquito based surveillance for detection of West Nile virus activity is not a successful tool 
for public health interventions in the state of Kansas.  Minimal funding limits the number of locations 
for mosquito collection and does not provide ample data that is representative of the state’s mosquito 
population.  Early detection of WNV in mosquito populations is aimed at allowing public health 
officials to implement prevention measures to limit human infections.  This method of surveillance is 
heavily reliant on timeliness of testing and reporting results from collected mosquito pools.  Time 
between date of first collection and date of reported test results is usually prolonged. This extended 
time period does not give local public health offices adequate time to implement mosquito control 
measures or release of public service announcements for preventative educational material in an 
effort to decrease human exposure.   
There is concern that another arboviral disease will enter the United States, if current 
surveillance efforts are discontinued leaving the nation in the same place it was back in 1999.  
Current methods of mosquito surveillance do not include testing for other arboviral disease and thus 
would not currently detect infection.  It is now known what resources are needed and available in the 
state to re-instigate surveillance if there is a need in the future.  The prevention and control measures 
for all arboviral diseases are the same and efforts should focus on educational material on vector 
control and prevention of bites instead of surveillance.       
 West Nile virus should now be considered an endemic disease and there is no longer a great 
need for mosquito based surveillance to occur in the state of Kansas.  WNV is an established seasonal 
health threat to residents of Kansas and resources would be better utilized if they were focused on 
educational efforts in disease prevention and mosquito control measures.  
 Improving education can be accomplished by implementing several different techniques.  One 
simple method would be to maintain an accurate and updated website.  Maps of WNV for Kansas 
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have not been updated since 2006 and may give the public the impression that there has not been 
WNV activity since then.  In addition, there could be increased outreach to county extension offices 
and to Master Gardener programs in the state.  Both of these organizations have contact with 
community members who are usually involved with outdoor activities.  This could be done by 
providing them with PSAs or website links to display on their websites.  These programs have often 
increased involvement with the community and the Master Gardener programs may be able to 
provide educational information to those citizens >55 years of age whom are at greater risk of severe 
disease.   
 Through previous surveillance efforts, the seasonality of WNV was able to be identified with 
human cases starting in mid-July and continuing through mid-October.  Timely public service 
announcements about mosquito control and prevention of mosquito bites should be released in June 
and again in August.  Releasing of public service announcements (PSAs) and having them 
broadcasted by local media has been problematic in the past.  In a 2003 evaluation of WNV 
education campaign in Kansas, evaluators found that no television or radio stations in a 10-county 
sample had broadcasted PSAs provided to them; only 5 of 23 newspapers printed the provided 
material.  In the 2003 evaluation, many stations have policies that prohibit opening of unsolicited e-
mails with attachments.   One idea to increase the utilization of PSAs by local media sources is to 
provide the resources through a secure link on the KDHE website and provide letters to 
administrators encourage the use of WNV public service announcements.  Although funding is 
limited, purchasing of advertising for the prevention of all vector borne diseases may prove to be 
useful.  
 Animal and avian cases are still tested at the Kansas State University Veterinary Diagnostic 
Laboratory.  This information was initially shared with KDHE and this distribution of results could 
be reintegrated into the WNV data base.  Although the numbers of animal and avian cases are 
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decreased and the level of effectiveness of this information is unknown at this time, this information 
is one cost-effective way of monitoring WNV activity in Kansas.     
 Continued public educational efforts should not only focus on the prevention of WNV, but 
should also focus on all vector borne diseases.  As incidence of WNV continues to decrease as 
expected, the level of concern of citizens is also expected to decrease.  One advantage of vector 
disease control is that no one wants to be bitten by mosquitoes.  Educational material about vector 
control and the use of personal protection against bites will be the future for WNV and other vector 
diseases.   
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Appendix A 
Time Between Non-Human and Human Cases in the Same County for 2003 
2003 Animal to Human (days) 
N= 17 
Avian to Human (days) 
N= 36 
Mosquito to Human(days) 
N=7 
Range 49 prior - 82 after 56 prior - 58 after 51 after - 5 after 
Median 14 after 3 after 37 after 
 
 
Time Between Non-Human and Human Cases in the Same County for 2004 
2004 Animal to Human (days) 
N= 2 
Avian to Human (days) 
N=13  
Mosquito to Human(days) 
N=5 
Range 39 after - 33 after 60 prior - 32 after 36 prior - 82 after 
Median N/A 9 prior 19 after 
 
 
Time Between Non-Human and Human Cases in the Same County for 2005 
2005 Animal to Human (days) 
N= 2 
Avian to Human (days) 
N= 0 
Mosquito to Human(days) 
N=2 
Range 19 prior - 84 after N/A 30 prior - 21 after 
Median N/A N/A N/A 
 
 
Time Between Non-Human and Human Cases in the Same County for 2006 
2006 Animal to Human (days) 
N= 2 
Avian to Human (days) 
N= 0 
Mosquito to Human(days) 
N=1 
Range 110 after - 23 after N/A 32 after 
Median N/A N/A N/A 
 
 
Time Between Non-Human and Human Cases in the Same County for 2007 
2007 Animal to Human (days) 
N= 1 
Avian to Human (days) 
N= 0 
Mosquito to Human(days) 
N=0 
Range 23 after N/A N/A 
 
 
Time Between Non-Human and Human Cases in the Same County for 2008 
2008 Animal to Human (days) 
N= 0 
Avian to Human (days) 
N= 0 
Mosquito to Human(days) 
N=0 
 N/A N/A N/A 
 
 
Time Between Non-Human and Human Cases in the Same County for 2009 
2009 Animal to Human (days) 
N= 0 
Avian to Human (days) 
N= 0 
Mosquito to Human(days) 
N=1 
Range N/A N/A 43 after  
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 Appendix C 
 
Missouri 
Karren Yates 
Vector Borne Disease Program Coordinator 
Division of Community and Public Health: Department of Health and Senior Services 
(573) 751-4749 
karren.yates@dhss.mo.gov 
 
Oklahoma 
Kristy Bradley, DVM, MPH 
State Public Health Veterinarian and State Epidemiologist 
Oklahoma State Department of Health 
(405) 271-4060 
kristyb@health.ok.gov 
 
Nebraska 
Annette Bredthauer MS, DVM, MPH 
State Public Health Veterinarian 
Nebraska Department of Health and Human Services: Public Health Support 
(402) 471-1374 
Annette.bredthauer@dhhs.ne.gov 
 
Colorado 
Elisabeth Lawaczeck, DVM 
State Public Health Veterinarian 
Colorado Department of Public Health and Environment: Communicable Disease Epidemiology 
Program 
(303) 692-2628 
Elisabeth.lawaczeck@state.co.us 
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